SCHEMBL7966928

SCHEMBL7966928

Cc1ccc(S(=O)(=O)O[C@@H]2CCN(c3ccncc3)C2)cc1

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 3/20 0.53
CYP1A2 P05177 2/20 0.48
HRH3 Q9Y5N1 2/20 0.40
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
MAPT P10636 3/20 0.38
GPR119 Q8TDV5 2/20 0.38
ACACB O00763 1/20 0.38
ITGB3 P05106 2/20 0.38
ITGA2B P08514 2/20 0.38
LSS P48449 2/20 0.37
ALDH1A1 P00352 1/20 0.37
LMNA P02545 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
TSHR P16473 1/20 0.36
CYP2C19 P33261 1/20 0.36
F10 P00742 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7964234 1.00 CYP2D6 (0.53) CYP2D6CYP1A2HRH3MEN1KMT2A
SCHEMBL8630790 1.00 CYP2D6 (0.53) CYP2D6CYP1A2HRH3MEN1KMT2A
SCHEMBL30773845 0.79 CYP2D6 (0.45) CYP2D6CYP1A2MEN1KMT2AMAPT
SCHEMBL2342353 0.79 CYP2D6 (0.52) CYP2D6CYP1A2MEN1KMT2AACACB
SCHEMBL3388527 0.77 CYP2D6 (0.74) CYP2D6CYP1A2KMT2AL3MBTL1CYP2C19
SCHEMBL420300 0.77 CYP2D6 (0.74) CYP2D6CYP1A2KMT2AL3MBTL1CYP2C19
SCHEMBL31342336 0.77 CYP2D6 (0.59) CYP2D6CYP1A2MEN1KMT2AMAPT
SCHEMBL2405904 0.76 CYP2D6 (0.52) CYP2D6CYP1A2MEN1KMT2AMAPT
SCHEMBL2405905 0.76 CYP2D6 (0.52) CYP2D6CYP1A2MEN1KMT2AMAPT
SCHEMBL1410427 0.76 MEN1 (0.53) CYP2D6CYP1A2MEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6313127-B1 FOR THERAPY OF HYPERCHOLESTEROLEMIA OR ATHEROSCLEROSIS ZENECA LIMITED (GB) 2001-11-06 US disclosed